Which right in medication administration refers to patient autonomy to decline treatment?

Prepare for the CJE Multidimensional Care 1 Test with detailed study materials, flashcards, and multiple-choice questions. Enhance your readiness with comprehensive practice questions and explanations. Elevate your exam confidence!

Multiple Choice

Which right in medication administration refers to patient autonomy to decline treatment?

Explanation:
In medication administration, patient autonomy means the patient has the final say about what happens to their body, including the choice to decline a treatment or medication. The right to refuse is the explicit expression of that autonomy, recognizing that a competent person can decide not to undergo or continue a prescribed intervention even if clinicians believe it would help. When a patient refuses, the clinician should ensure the patient understands the potential benefits and risks, explore concerns, and verify capacity to decide. It’s also important to document the refusal and any discussion, and to establish a plan for monitoring and safety in case the decision changes. The right to privacy concerns keeping personal health information confidential, not whether treatment should be accepted or declined. The right to consent covers agreeing to treatment after being informed of risks and benefits; it’s about permission to proceed, not a declaration of choosing to withhold treatment. The idea of a right to modify isn’t a standard term for patient rights in this context, though patients may negotiate aspects of their care. The refusal remains the clear expression of patient choice in medication administration.

In medication administration, patient autonomy means the patient has the final say about what happens to their body, including the choice to decline a treatment or medication. The right to refuse is the explicit expression of that autonomy, recognizing that a competent person can decide not to undergo or continue a prescribed intervention even if clinicians believe it would help. When a patient refuses, the clinician should ensure the patient understands the potential benefits and risks, explore concerns, and verify capacity to decide. It’s also important to document the refusal and any discussion, and to establish a plan for monitoring and safety in case the decision changes.

The right to privacy concerns keeping personal health information confidential, not whether treatment should be accepted or declined. The right to consent covers agreeing to treatment after being informed of risks and benefits; it’s about permission to proceed, not a declaration of choosing to withhold treatment. The idea of a right to modify isn’t a standard term for patient rights in this context, though patients may negotiate aspects of their care. The refusal remains the clear expression of patient choice in medication administration.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy